Oversight and Administration of the 340B Drug Discount Program:
Improving Efficiency and Transparency

House Energy and Commerce Committee
Subcommittee on Oversight and Investigations

December 15, 2005
 

• Testimony of Dennis Williams, Deputy Administrator, HRSA
   

• Testimony of Stuart Wright, Deputy Inspector General for Evaluation and Inspections, HHS
   

• Testimony of William von Oehsen, General Counsel, Public Hospital Pharmacy Coalition
   

• Testimony of David B. Brown, Director of Government Contracts and Pricing Programs, GlaxoSmithKline
   

• Testimony of Chris Hatwig, Senior Director, 340B Prime Vendor Program